Christopher Nixon Cox serves as Executive at Alto Neuroscience, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Nixon Cox has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 7,189 shares valued at $85.0K.
Christopher Nixon Cox currently holds 7,189 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Nixon Cox has been a net neutral trader of ANRO stock. They have purchased $0 and sold $0 worth of shares.
Christopher Nixon Cox's most recent insider trade was on Jan 2, 2026, when they sold 7,189 shares at $11.82 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 6, 2024 | ANRO | $0 | Conversion | 126,755 | $N/A | Discretionary |